Loading...
•
Dec 31, 2023
Amedisys Q4 2023 Earnings Report
Amedisys's Q4 2023 financial results reflected a slight increase in net service revenue, offset by a decrease in net income due to merger-related expenses.
Key Takeaways
Amedisys reported a slight increase in net service revenue for Q4 2023, but net income was negatively impacted by merger-related costs. The company's adjusted EBITDA also saw a decrease compared to the previous year.
Net service revenue increased to $570.8 million from $562.0 million in Q4 2022.
Net income attributable to Amedisys, Inc. was $19.3 million, compared to $31.7 million in Q4 2022, impacted by $11.5 million in merger transaction costs.
Adjusted EBITDA decreased to $56.7 million from $59.9 million in the prior year.
Adjusted net income attributable to Amedisys, Inc. was $30.8 million, compared to $38.0 million in 2022.
Amedisys
Amedisys
Forward Guidance
Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year ended December 31, 2023 results in light of the pending merger of the Company with UnitedHealth Group Incorporated.